Page 22 - மருத்துவ ஆய்வகம் முன்னேற்றம் திருத்தங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Dementia Drugs Market Expected to Exceed $19.6 Billion In 2026 - FinancialNewsMedia.com News Commentary PALM BEACH, Fla., April 20, 2021 /PRNewswire/ While this past year living in quarantine during the pandemic did not just create economical damage, and social disruption… it could have also increased new cases of secondary medical results from the pandemic. According to various reports the outbreak of the COVID-19 pandemic is expected to have a significant impact on the Dementia drugs market. According to a research study by Katya Numbers et al., published in Nature Reviews Neurology, in January 2021, the population with dementia are at high risk of contracting COVID-19 infection as the cognitive symptoms cause difficulty to abide by the safety guidelines that were proposed to contain the viral spread. Furthermore, older populations with dementia are also more likely to have more severe disease consequences than those without dementia. Additionally, the statement from

United statesUnited kingdomCharles strongoKostenloser wertpapierhandelCarmen castrillo vigueraMovement disorder program at global neuroscience instituteFn media groupAnavex life sciences corpQuidel corporationParkinson movement disorder allianceAdamas pharmaceuticals incGlobal wholehealth partners corpDrug administrationOffice for national statistics united kingdomAdamas pharmaceuticalsExchange commission